<DOC>
	<DOCNO>NCT00702624</DOCNO>
	<brief_summary>The objective follow-up study evaluate whether corifollitropin alfa ( Org 36286 ) treatment induction multifollicular growth woman undergo controlled ovarian stimulation ( COS ) prior vitro fertilization ( IVF ) intracytoplasmic sperm injection ( ICSI ) safe pregnant participant offspring .</brief_summary>
	<brief_title>Pregnancy Neonatal Follow-up Ongoing Pregnancies Established Clinical Trial P05690 ( Care Program ) ( P05710 )</brief_title>
	<detailed_description>This follow-up protocol prospectively monitor pregnancy , delivery , neonatal outcome woman treat corifollitropin alfa recFSH become pregnant base study P05690 ( NCT00702845 ) . For trial study specific assessment require , information obtain standard practice use .</detailed_description>
	<mesh_term>Hormones</mesh_term>
	<mesh_term>Progesterone</mesh_term>
	<mesh_term>Follicle Stimulating Hormone</mesh_term>
	<mesh_term>Ganirelix</mesh_term>
	<criteria>Participants participate base study P05690 ( NCT00702845 ) receive least one dose either corifollitropin alfa ( Org 36286 ) recFSH base study P05690 ; Ongoing pregnancy confirm ultrasound least 10 week embryo transfer base study P05690 ; Able willing give write informed consent .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>36 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Neonatal outcome</keyword>
	<keyword>Congenital malformation</keyword>
	<keyword>In-Vitro fertilization</keyword>
	<keyword>Controlled ovarian stimulation</keyword>
	<keyword>Follow-up</keyword>
</DOC>